Astragaloside II - CAS 84676-89-1

Astragaloside II (Astrasieversianin VIII) is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy. Astragaloside II also induces osteogenic activities, differentiation, proliferation, and mineralization, through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.

Interleukin, Autophagy, HIF/HIF Prolyl-Hydroxylase, NF-κB, TGF-beta/Smad

Metabolism, Immunology/Inflammation, Autophagy, Chromatin/Epigenetic, NF-κB, Stem Cells

84586

0.997

C43H70O15

827.01

CC(=O)O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1CC[C@]23C[C@]22CC[C@]4(C)[C@H]([C@@H](O)C[C@@]4(C)[C@@H]2C[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]3C1(C)C)[C@@]1(C)CC[C@H](O1)C(C)(C)O

-20°C

Ice Packs

Natural Product